ABSTRACT
Introduction Weakness is a natural age-related condition meaning the loss of muscle strength that impairs older adults’ mobility and quality of life. Because the relationship between muscle strength and body-size variables is non-linear, weakness is misclassified in older adults with extreme body size (e.g., light, short, heavy, or tall). This misclassification can be overcome using the allometric approach.
Objectives To propose cut-off points for older adults’ weakness for upper and lower limbs muscle strength normalized by body size with the ratio standard and allometric scaling.
Methods Ninety-four community-dwelling older adults (69.1% women) were assessed for 49 body-size variables (anthropometry, body composition and body indexes), handgrip strength (HGS), one maximum repetition measurement for knee extensors (1RMknee extensors), isokinetic knee extension peak torque at 60°/s (knee extensionPT60°/s), and six-minute walk test (6MWT). Ratio standard (muscle strength/body size) and allometric scaling (muscle strength/body sizeb; when b is the allometric exponent) were applied for body-size variables that significantly were correlated with HGS, 1RMknee extensors and knee extensionPT60°/s. Cut-off points were computed based on ROC curve and Youden index. When there was mobility limitation (6MWT<400m) cut-off were computed according to sex.
Results Absolute HGS, 1RMknee extensors and knee extensionPT60°/s cut-off points were not adequate because they were associated with body size (r>0.30). But it was corrected with muscle strength normalization according to body size-variables: HGS (n=1); 1RMknee extensors (n=24) and knee extensionPT60°/s (n=24). The best cut-off points, with the highest area under the curve (AUC), were found after normalization for men: HGS/forearm circumference (1.33 kg/cm, AUC=0.74), 1RMknee extensors/triceps skinfold (4.22 kg/mm, AUC=0.81), and knee extensionPT60°/s/body mass*height0.43 (13.0 Nm/kg*m0.43, AUC=0.94); and for women: HGS/forearm circumference (1.04 kg/cm, AUC=0.70), 1RMknee extensors/body mass (0.54 kg/kg, AUC=0.76); and knee extensionPT60°/s/body mass0.72 (3.14 Nm/kg0.72; AUC=0.82).
Conclusion Normalization removes the effect of extreme body size on muscle strength and improves the accuracy to identify weakness at population level, reducing the risk of false-positive cases.
Highlights
This study proposed a new approach to identify muscle weakness in older adults based on upper and lower limbs muscle strength normalized by body size (ratio standard and allometry).
The identification of functional limitation is more precise when procedures of muscle strength normalization is applied.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Coordination for the Improvement of Higher Education Personnel (CNPq) [through PhD scholarship number 142248/2018-5 granted to Pedro Pugliesi Abdalla]; and the Coordination for the Improvement of Higher Education Personnel (CAPES) [finance Code 001, through PhD scholarship number 88887.593242/2020-00 granted to Pedro Pugliesi Abdalla, and through scholarship number 88887.371516/2019-00 granted to Dalmo Roberto Lopes Machado]. The funding body had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the University Hospital of Ribeirao Preto School of Medicine, University of Sao Paulo, Brazil (HC-FMRP-USP) institutional review board
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declaration of Conflicting Interests The Author(s) declare(s) that there is no conflict of interest.
Funding This work was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) [through PhD scholarship number 142248/2018–5 granted to Pedro Pugliesi Abdalla]; and the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) [finance Code 001, through PhD scholarship number 88887.593242/2020-00 granted to Pedro Pugliesi Abdalla, and through scholarship number 88887.371516/2019-00 granted to Dalmo Roberto Lopes Machado]. The funding body had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
Data Availability
The data that support the findings of this study are available from the corresponding author, [PPA], upon reasonable request.